Literature DB >> 25166909

Molybdenum site structure of MOSC family proteins.

Logan J Giles1, Christian Ruppelt, Jing Yang, Ralf R Mendel, Florian Bittner, Martin L Kirk.   

Abstract

Mo K-edge X-ray absorption spectroscopy has been used to probe as-isolated structures of the MOSC family proteins pmARC-1 and HMCS-CT. The Mo K-edge near-edge spectrum of HMCS-CT is shifted ~2.5 eV to lower energy compared to the pmARC-1 spectrum, which indicates that as-isolated HMCS-CT is in a more reduced state than pmARC-1. Extended X-ray absorption fine structure analysis indicates significant structural differences between pmARC-1 and HMCS-CT, with the former being a dioxo site and the latter possessing only a single terminal oxo ligand. The number of terminal oxo donors is consistent with pmARC-1 being in the Mo(VI) oxidation state and HMCS-CT in the Mo(IV) state. These structures are in accord with oxygen-atom-transfer reactivity for pmARC-1 and persulfide bond cleavage chemistry for HMCS-CT.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25166909      PMCID: PMC4164224          DOI: 10.1021/ic5015863

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


Members of the molybdenum cofactor (Moco) sulfurase C-terminal (MOSC) domain superfamily of pyranopterin molybdenum (Mo) proteins are known to play significant roles in Moco maturation, prodrug activation, detoxification of possible mutagens, and the regulation of intracellular nitric oxide (NO) levels.[1−4] Moco sulfurase proteins are essential for the activation of Mo enzymes of the xanthine oxidase family. In this activation process, the N-terminal domain of Moco sulfurase decomposes free l-cysteine with concomitant release of sulfur, which is subsequently transferred to the Moco that is bound to the C-terminal domain of the protein.[5,6] Once sulfurated Moco is generated, the MOSC domain is capable of activating its target enzymes in a final maturation step. In addition to Moco sulfurases, the MOSC superfamily in eukaryotes also comprises the mitochondrial amidoxime reducing component (mARC) proteins, which are located in the outer mitochondrial membrane and catalyze the Moco-dependent reduction of a diverse range of N-hydroxylated substrates that include amidoximes, N-hydroxysulfonamides, and N-hydroxyguanidines.[4,7−12] Many of these substrates serve as prodrugs that are readily absorbed in the stomach and intestines and then are converted to their active forms by mARC enzymes. In spite of the role that mARC plays in prodrug activation, its exact biological function remains elusive. Yet, because of the known function of Moco sulfurases, a general role of MOSC proteins in metalsulfur cluster biogenesis has been discussed.[13] Both mARC and Moco sulfurase have been shown to be related based on their sequence similarity[13,14] but have yet to be characterized by X-ray crystallography. This fundamental gap in the knowledge base has hindered our ability to determine key structure/function relationships for MOSC family proteins. Here, we use a combination of X-ray absorption near-edge structure (XANES) and extended X-ray absorption fine structure (EXAFS) at the Mo K-edge to probe the coordination environment of plant mARC isoform 1 (pmARC-1) and the human Moco sulfurase C-terminal domain (HMCS-CT). The XANES spectra for as-isolated, aerobic pmARC-1 and HMCS-CT are presented in Figure 1. These spectra derive from the promotion of a Mo 1s core electron to valence molecular orbitals and are therefore sensitive probes of the geometric and electronic structures of the Mo sites.[15] The XANES spectrum of pmARC-1 is shifted ∼2.5 eV to higher energy relative to that of HMCS-CT, which indicates that as-isolated pmARC-1 is more oxidized than HMCS-CT. The 1s → Mo≡O transition is clearly observed at ∼20,006 eV in the pmARC-1 spectrum, and its relative intensity is indicative of a greater number of terminal oxo ligands[16−20] bound to the Mo ion in pmARC-1 compared to HMCS-CT. This observation, coupled with the ∼2.5 eV edge shift, is consistent with the Mo ion of pmARC-1 being a dioxo MoVI site and HMCS-CT possessing a monooxo MoIV site.[21]
Figure 1

Mo K-edge XANES spectra of as-isolated HMCS-CT (black) and as-isolated pmARC-1 (red). Inset: Complete k = 18 spectra.

Mo K-edge XANES spectra of as-isolated HMCS-CT (black) and as-isolated pmARC-1 (red). Inset: Complete k = 18 spectra. We have used EXAFS to determine the number of terminal oxo ligands and provide details regarding the nature of the first coordination sphere. The pmARC-1 EXAFS and best fit to the data are presented in Figure 2. The best fit to the data reveals a single oxygen shell consisting of two terminal oxo ligands (mean dMo≡O = 1.76 Å) and one sulfur shell comprised of three sulfur donors (mean dMo–S = 2.47 Å). Additional fits to the data are included in Table 1. The presence of two terminal oxo donors is consistent with the observation of the intense 1s → Mo≡O transition that is observed in the pmARC-1 XANES spectrum. Analysis of the EXAFS data results in a proposed structure (Figure 4A) for pmARC-1 that is remarkably similar to oxidized sulfite oxidase (SO), with two terminal oxo ligands, a pyranopterin dithiolene, and a coordinated cysteine. Although the electron paramagnetic resonance spectra of pmARC and the “low-pH” forms of SO are similar,[28] pmARC-1 does not possess the SO (SUOX) fold,[22] suggesting that the MOCS family proteins are distinct from the SO family enzymes. As such, there is no a priori evidence that suggests that mARC and the SO family enzymes possess similar active site geometries.
Figure 2

Mo EXAFS of pmARC-1 (black) and the corresponding FT of fit 1-1 (green). Inset: (top) Mo=O (red) and Mo–S (purple) scattering paths that contribute to the overall fit; (middle) k-space data for pmARC-1 (black) and fit 1-1 (green); (bottom) residual (blue).

Table 1

EXAFS Curve-Fitting Results for MOSC Proteins

  Mo≡O
Mo–S
Mo–O
  
 fitNRσ2NRσ2NRσ2ΔE0RF (%)
pmARC-1fit 1-12.01.760.0023.02.470.013   –3.768.79
 fit 1-23.01.760.0052.02.450.009   –5.4815.79
 fit 1-33.01.760.0053.02.450.013   –5.7813.38
 fit 1-41.01.760.001a3.02.430.0101.02.430.001a–6.9433.98
 model 1-1b21.71 32.46      
HMCS-CTfit 2-11.01.710.0023.02.380.0061.02.490.004–8.975.51
 fit 2-21.01.710.0023.02.370.006   –7.976.66
 fit 2-32.01.720.0082.02.370.006   –7.2412.09
 model 2-1c11.69 32.36 12.31   
 model 2-2d11.70 32.34      

The σ2 value was fixed to 0.001 to avoid negative σ2 values.

Geometry-optimized model structure consistent with fit 1-1.

Geometry-optimized model structure consistent with fit 2-1.

Geometry-optimized model structure consistent with fit 2-2. Details on the model calculations are given in the Supporting Information.

Figure 4

Possible structures for as-isolated pmARC-1 (A) and HMCS-CT (B) determined from XAS. (C) Internal redox conversion of the molybdenum(IV) persulfide to form a MoVI=S species and uncoordinated cysteine.

Mo EXAFS of pmARC-1 (black) and the corresponding FT of fit 1-1 (green). Inset: (top) Mo=O (red) and Mo–S (purple) scattering paths that contribute to the overall fit; (middle) k-space data for pmARC-1 (black) and fit 1-1 (green); (bottom) residual (blue). The σ2 value was fixed to 0.001 to avoid negative σ2 values. Geometry-optimized model structure consistent with fit 1-1. Geometry-optimized model structure consistent with fit 2-1. Geometry-optimized model structure consistent with fit 2-2. Details on the model calculations are given in the Supporting Information. The HMCS-CT EXAFS (Figure 3) is markedly different from that of pmARC-1, as was anticipated from the differences observed in the XANES spectra. More specifically, the relative intensities of the oxo shell at 1.71 Å and sulfur shell at 2.47 Å are reversed with respect to the pmARC data, and this indicates that the ratio of oxo to sulfur ligands in HMCS-CT is different from that observed for pmARC-1. The best fit to the HMCS-CT EXAFS is obtained with two oxygen shells consisting of a single terminal oxo ligand (dMo≡O = 1.70 Å) and a longer Mo–O vector at 2.49 Å, and a single sulfur shell comprised of three sulfur donors (mean dMo–S = 2.47 Å). Analysis of the HMCS-CT EXAFS data results in the proposed structure depicted in Figure 4B, where the MoIV ion is coordinated by a single terminal oxo, a pyranopterin dithiolene, a cysteine or cysteine persulfide,[2,6] and possibly a weakly bound aqua ligand or light atom donor (i.e., nitrogen, oxygen) from a protein-derived ligand. Attempts to model the data with a coordinated persulfide donor did not improve the quality of the fit. Thus, the coordination geometry of as-isolated HMCS-CT appears to be similar to that of reduced SO family enzymes.
Figure 3

Mo EXAFS for HMCS-CT (black) and the corresponding FT of fit 2-1 (green). Inset: (top) Mo≡O (red), Mo–O (orange), and Mo–S (purple) scattering paths that contribute to the overall fit; (middle) k-space data for HMCS-CT (black) and fit 2-1 (green); (bottom) residual (blue).

Mo EXAFS for HMCS-CT (black) and the corresponding FT of fit 2-1 (green). Inset: (top) Mo≡O (red), Mo–O (orange), and Mo–S (purple) scattering paths that contribute to the overall fit; (middle) k-space data for HMCS-CT (black) and fit 2-1 (green); (bottom) residual (blue). Possible structures for as-isolated pmARC-1 (A) and HMCS-CT (B) determined from XAS. (C) Internal redox conversion of the molybdenum(IV) persulfide to form a MoVI=S species and uncoordinated cysteine. In summary, we have used Mo K-edge X-ray absorption spectroscopy (XAS) to illuminate differences in the coordination geometry of the MOSC family proteins pmARC-1 and HMCS-CT. The proposed structure of as-isolated pmARC-1 is consistent with a dioxo MoVI site similar to that found for oxidized enzymes of the SO family. While the exact biological function of the mARC proteins is not known, mARC proteins have been shown to function as oxygen-atom-transfer catalysts in the reduction of amidoxime prodrug substrates. Thus, the structure supports a proposed catalytic cycle with the Mo ion cycling between monooxo MoIV and dioxo MoVI oxidation states and an oxygen atom transferring from the substrate to the Mo center. Two sequential e–/H+ transfer steps regenerate the catalytically competent MoIV state. The XAS structure proposed for HMCT-CT is unique in that it is the only human pyranopterin molybdenum protein that is in the reduced monooxo MoIV state in its as-isolated form. The MoIV oxidation state is consistent with HMCS-CT accepting a sulfur atom from the HMCS N-terminal domain to form a Mo-bound cysteine persulfide. Persulfide coordination to Mo has been suggested for HMCS[2,6] and periplasmic nitrate reductases.[23−25] An induced internal electron transfer from MoIV to the Mo-bound cysteine persulfide would then result in cleavage of the persulfide bond and transfer of the sulfane (terminal) sulfur to the Mo as a bound sulfido ligand (Figure 4C) prior to transfer of the intact cofactor into apo XO. Such induced internal electron-transfer reactivity between Mo and persulfides was shown by Stiefel and co-workers over 30 years ago.[26,27] Our initial calculations show that the molybdenum(IV) persulfide is a stable species but can convert to the MoVI=S form by protonation of the bridging persulfide sulfur with subsequent or concurrent deprotonation of the aqua ligand.
  21 in total

1.  Molybdenum site structure of Escherichia coli YedY, a novel bacterial oxidoreductase.

Authors:  M Jake Pushie; Christian J Doonan; Kamila Moquin; Joel H Weiner; Richard Rothery; Graham N George
Journal:  Inorg Chem       Date:  2010-12-29       Impact factor: 5.165

2.  Biochemical and spectroscopic characterization of the human mitochondrial amidoxime reducing components hmARC-1 and hmARC-2 suggests the existence of a new molybdenum enzyme family in eukaryotes.

Authors:  Bettina Wahl; Debora Reichmann; Dimitri Niks; Nina Krompholz; Antje Havemeyer; Bernd Clement; Tania Messerschmidt; Martin Rothkegel; Harald Biester; Russ Hille; Ralf R Mendel; Florian Bittner
Journal:  J Biol Chem       Date:  2010-09-22       Impact factor: 5.157

3.  Identification of the missing component in the mitochondrial benzamidoxime prodrug-converting system as a novel molybdenum enzyme.

Authors:  Antje Havemeyer; Florian Bittner; Silke Wollers; Ralf Mendel; Thomas Kunze; Bernd Clement
Journal:  J Biol Chem       Date:  2006-09-13       Impact factor: 5.157

4.  Molybdenum enzymes in higher organisms.

Authors:  Russ Hille; Takeshi Nishino; Florian Bittner
Journal:  Coord Chem Rev       Date:  2011-05-01       Impact factor: 22.315

5.  Structure of the active site of sulfite oxidase. X-ray absorption spectroscopy of the Mo(IV), Mo(V), and Mo(VI) oxidation states.

Authors:  G N George; C A Kipke; R C Prince; R A Sunde; J H Enemark; S P Cramer
Journal:  Biochemistry       Date:  1989-06-13       Impact factor: 3.162

Review 6.  The fourth mammalian molybdenum enzyme mARC: current state of research.

Authors:  Antje Havemeyer; Juliane Lang; Bernd Clement
Journal:  Drug Metab Rev       Date:  2011-09-26       Impact factor: 4.518

Review 7.  The mononuclear molybdenum enzymes.

Authors:  Russ Hille; James Hall; Partha Basu
Journal:  Chem Rev       Date:  2014-01-28       Impact factor: 60.622

8.  Reduction of N-hydroxy-sulfonamides, including N-hydroxy-valdecoxib, by the molybdenum-containing enzyme mARC.

Authors:  Antje Havemeyer; Sanja Grünewald; Bettina Wahl; Florian Bittner; Ralf Mendel; Péter Erdélyi; János Fischer; Bernd Clement
Journal:  Drug Metab Dispos       Date:  2010-08-10       Impact factor: 3.922

9.  Reduction of N(ω)-hydroxy-L-arginine by the mitochondrial amidoxime reducing component (mARC).

Authors:  Jürke Kotthaus; Bettina Wahl; Antje Havemeyer; Joscha Kotthaus; Dennis Schade; Dieter Garbe-Schönberg; Ralf Mendel; Florian Bittner; Bernd Clement
Journal:  Biochem J       Date:  2011-01-15       Impact factor: 3.857

10.  Binding of sulfurated molybdenum cofactor to the C-terminal domain of ABA3 from Arabidopsis thaliana provides insight into the mechanism of molybdenum cofactor sulfuration.

Authors:  Silke Wollers; Torsten Heidenreich; Maryam Zarepour; Dieter Zachmann; Claudia Kraft; Yunde Zhao; Ralf R Mendel; Florian Bittner
Journal:  J Biol Chem       Date:  2008-02-07       Impact factor: 5.157

View more
  8 in total

1.  Cloning and functional validation of molybdenum cofactor sulfurase gene from Ammopiptanthus nanus.

Authors:  Hao Qiang Yu; Yuan Yuan Zhang; Tai Ming Yong; Yan Ping Liu; Shu Feng Zhou; Feng Ling Fu; Wan Chen Li
Journal:  Plant Cell Rep       Date:  2015-02-27       Impact factor: 4.570

2.  Crystal structure of human mARC1 reveals its exceptional position among eukaryotic molybdenum enzymes.

Authors:  Christian Kubitza; Florian Bittner; Carsten Ginsel; Antje Havemeyer; Bernd Clement; Axel J Scheidig
Journal:  Proc Natl Acad Sci U S A       Date:  2018-11-05       Impact factor: 11.205

3.  Addressing Ligand-Based Redox in Molybdenum-Dependent Methionine Sulfoxide Reductase.

Authors:  Laura J Ingersol; Jing Yang; Khadanand Kc; Amrit Pokhrel; Andrei V Astashkin; Joel H Weiner; Christopher A Johnston; Martin L Kirk
Journal:  J Am Chem Soc       Date:  2020-01-28       Impact factor: 15.419

4.  Oxyl and hydroxyl radical transfer in mitochondrial amidoxime reducing component-catalyzed nitrite reduction.

Authors:  Jing Yang; Logan J Giles; Christian Ruppelt; Ralf R Mendel; Florian Bittner; Martin L Kirk
Journal:  J Am Chem Soc       Date:  2015-04-21       Impact factor: 15.419

Review 5.  The mammalian molybdenum enzymes of mARC.

Authors:  Gudrun Ott; Antje Havemeyer; Bernd Clement
Journal:  J Biol Inorg Chem       Date:  2014-11-26       Impact factor: 3.358

6.  Molybdenum and Tungsten Cofactors and the Reactions They Catalyze.

Authors:  Martin L Kirk; Khadanand Kc
Journal:  Met Ions Life Sci       Date:  2020-03-23

7.  Implications of Pyran Cyclization and Pterin Conformation on Oxidized Forms of the Molybdenum Cofactor.

Authors:  Douglas R Gisewhite; Jing Yang; Benjamin R Williams; Alisha Esmail; Benjamin Stein; Martin L Kirk; Sharon J N Burgmayer
Journal:  J Am Chem Soc       Date:  2018-10-02       Impact factor: 15.419

Review 8.  Spectroscopic Studies of Mononuclear Molybdenum Enzyme Centers.

Authors:  Martin L Kirk; Russ Hille
Journal:  Molecules       Date:  2022-07-27       Impact factor: 4.927

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.